Glutathione vs NAC: Direct Supplementation vs Precursor Strategy

NAC is generally more cost-effective with a longer safety track record and FDA-recognized uses. Direct (liposomal) glutathione may benefit those with impaired synthesis capacity. For most people, NAC is the practical first choice — consult your healthcare provider.

Standard oral glutathione is largely degraded in the GI tract (<5% bioavailability). However, Richie et al. (2015) showed oral GSH (250–1,000 mg/day for 6 months) increased body glutathione stores. Liposomal and sublingual forms improve absorption further.

NAC is FDA-approved as a drug for acetaminophen overdose and as a mucolytic. It's also studied for COPD (20-25% fewer exacerbations), liver support, and as a glutathione precursor. It's one of the most broadly researched supplement compounds (60+ conditions studied).

NAC: typically 600–1,200 mg/day (up to 1,800 mg in studies). Glutathione (liposomal): 250–1,000 mg/day. Doses differ due to different absorption and conversion characteristics.

NAC costs ~$0.10–0.30/day at therapeutic doses. Liposomal glutathione costs ~$1–3/day. NAC is significantly more cost-effective for raising glutathione levels.

Combining them has not been specifically studied, but there's no known adverse interaction. NAC supports glutathione synthesis while direct glutathione provides the end product. Consult your healthcare provider before combining.

NAC is generally well-tolerated. Possible effects include GI upset, nausea, and a sulfur smell/taste. At high doses, it may have a mild blood-thinning effect. FDA-approved uses have established safety profiles.

Glutathione is the most abundant intracellular antioxidant, present at millimolar concentrations in virtually every human cell. It recycles other antioxidants (vitamins C and E) and detoxifies peroxides via glutathione peroxidase.

IV glutathione bypasses GI degradation entirely and achieves high blood levels. However, IV use is more invasive, costly, and lacks long-term safety data for wellness use. Oral liposomal forms offer a practical middle ground.

Glutathione levels decline 20-40% between young adulthood and age 60-70, due to reduced synthesis capacity and increased oxidative consumption. This decline contributes to age-related oxidative stress.

GlyNAC (glycine + NAC) supplementation restored glutathione levels and improved multiple aging biomarkers in older adults within 16 weeks (Kumar 2021). Adding glycine addresses a second limiting amino acid for glutathione synthesis.

Yes — NAC reduces COPD exacerbations by 20-25% at 600-1,200 mg/day (meta-analysis) and is FDA-approved as a mucolytic to thin mucus. It's one of the best-studied supplements for respiratory health.

NAC is the standard treatment for acetaminophen (paracetamol) overdose, replenishing glutathione to prevent liver damage. It's also studied for other liver conditions with supportive but less definitive evidence.

Sulfur-rich foods (garlic, onions, cruciferous vegetables), protein (provides cysteine and glycine), and vitamin C support glutathione synthesis. However, dietary impact on levels is modest compared to supplementation.

S-acetyl glutathione is marketed as more stable and bioavailable than standard oral glutathione, but robust human pharmacokinetic comparisons are limited. Liposomal forms currently have the strongest absorption evidence.